Zevra Therapeutics Inc (ZVRA) Directors and Executive Officers

Officers & Directors

R. LaDuane Clifton, MBA, CPA
Chief Financial Officer, Secretary and Treasurer - (Principal Financial Officer)

Neil F. McFarlane
President and Chief Executive Officer - (Principal Executive Officer)

Douglas,

Zevra Therapeutics Inc currently has 61 employees.

News about Zevra Therapeutics Inc Key Personnel

Zevra Therapeutics Gains Strong Support from Proxy Firms Amid Record Growth and Disease Awareness Initiative,

In a notable development within the biotechnology and pharmaceutical sector, all three leading proxy advisory firms, Institutional Shareholder Services (ISS), Glass Lewis, and Egan-Jones, have unanimously recommended that Zevra Therapeutics Inc. stockholders vote in favor of the company’s director nominees. This consensus comes in the wake of a rising chorus of challenges from activist investor proposals, underscoring the strength and potential of Zevra s management and strategic vision. Key Insights:1. Unanimous Endorsement from Proxy Firms: - ISS, Glass Lewis, and Egan-Jones concluded that dissident investor Frank Mangless has not provided a compelling case for change within the company. Their endorse...

Zevra Therapeutics Announces Organizational Changes

Article for the CSI MarketZevra Therapeutics: Transformational Challenges Amidst Financial Strain in Rare Disease TherapeuticsCELEBRATION, Fla. — In a striving industry defined by rapid innovation and harsh competition, Zevra Therapeutics, Inc. (NASDAQ: ZVRA) finds itself at a critical juncture. The company, dedicated to addressing the unmet therapeutic needs of patients afflicted by rare diseases, recently implemented significant organizational changes aimed at redefining its future trajectory. Yet, behind this ambitious transformation lurks a troubling financial backdrop that raises questions about its sustainability.As of the third quarter of 2024, Zevra recorded a staggering cumulative net loss of $8...